These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 24756010)
1. Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease. Beaton MD; Chakrabarti S; Adams PC Ann Hepatol; 2014; 13(3):353-6. PubMed ID: 24756010 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease. Buzzetti E; Petta S; Manuguerra R; Luong TV; Cabibi D; Corradini E; Craxì A; Pinzani M; Tsochatzis E; Pietrangelo A Liver Int; 2019 Jul; 39(7):1325-1334. PubMed ID: 30851216 [TBL] [Abstract][Full Text] [Related]
3. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease. Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701 [TBL] [Abstract][Full Text] [Related]
4. How should hyperferritinaemia be investigated and managed? Ong SY; Nicoll AJ; Delatycki MB Eur J Intern Med; 2016 Sep; 33():21-7. PubMed ID: 27346296 [TBL] [Abstract][Full Text] [Related]
5. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316 [TBL] [Abstract][Full Text] [Related]
6. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease. Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592 [TBL] [Abstract][Full Text] [Related]
7. Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up. Hagström H; Nasr P; Bottai M; Ekstedt M; Kechagias S; Hultcrantz R; Stål P Liver Int; 2016 Nov; 36(11):1688-1695. PubMed ID: 27064133 [TBL] [Abstract][Full Text] [Related]
8. Iron stores assessment in alcoholic liver disease. Costa Matos L; Batista P; Monteiro N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Carvalho A Scand J Gastroenterol; 2013 Jun; 48(6):712-8. PubMed ID: 23534461 [TBL] [Abstract][Full Text] [Related]
9. Hepatic iron is the major determinant of serum ferritin in NAFLD patients. Ryan JD; Armitage AE; Cobbold JF; Banerjee R; Borsani O; Dongiovanni P; Neubauer S; Morovat R; Wang LM; Pasricha SR; Fargion S; Collier J; Barnes E; Drakesmith H; Valenti L; Pavlides M Liver Int; 2018 Jan; 38(1):164-173. PubMed ID: 28679028 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease. Valenti L; Dongiovanni P; Fargion S World J Gastroenterol; 2012 Aug; 18(29):3782-6. PubMed ID: 22876027 [TBL] [Abstract][Full Text] [Related]
11. Circulating Iron Levels Interaction with Central Obesity on the Risk of Nonalcoholic Fatty Liver Disease: A Case-Control Study in Southeast China. Pan X; Chen B; Liu W; Li Y; Hu Z; Lin X; Xu S; Peng XE Ann Nutr Metab; 2019; 74(3):207-214. PubMed ID: 30870854 [TBL] [Abstract][Full Text] [Related]
12. Relationship between hemoglobin levels and risk for suspected non-alcoholic fatty liver in Taiwanese adults. Bai CH; Wu MS; Owaga E; Cheng SY; Pan WH; Chang JS Chin J Physiol; 2014 Oct; 57(5):286-94. PubMed ID: 25241989 [TBL] [Abstract][Full Text] [Related]
13. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. Lecube A; Hernández C; Simó R Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865 [TBL] [Abstract][Full Text] [Related]
14. Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease. Beaton MD; Chakrabarti S; Levstik M; Speechley M; Marotta P; Adams P Aliment Pharmacol Ther; 2013 Apr; 37(7):720-9. PubMed ID: 23441892 [TBL] [Abstract][Full Text] [Related]
15. Potential mediation effect of insulin resistance on the association between iron metabolism indicators and non-alcoholic fatty liver disease. Zhang X; Han XY; Fan H; Guo CN; Li Y; Wang HL; Liu ZQ; Zhang TJ J Dig Dis; 2024 May; 25(5):285-297. PubMed ID: 38946678 [TBL] [Abstract][Full Text] [Related]
16. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. Stechemesser L; Eder SK; Wagner A; Patsch W; Feldman A; Strasser M; Auer S; Niederseer D; Huber-Schönauer U; Paulweber B; Zandanell S; Ruhaltinger S; Weghuber D; Haschke-Becher E; Grabmer C; Rohde E; Datz C; Felder TK; Aigner E Mol Metab; 2017 Jan; 6(1):38-47. PubMed ID: 28123936 [TBL] [Abstract][Full Text] [Related]
17. Serum Iron:Ferritin Ratio Predicts Healthy Body Composition and Reduced Risk of Severe Fatty Liver in Young Adult Women. Sabrina N; Bai CH; Chang CC; Chien YW; Chen JR; Chang JS Nutrients; 2017 Aug; 9(8):. PubMed ID: 28777296 [TBL] [Abstract][Full Text] [Related]
18. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730 [TBL] [Abstract][Full Text] [Related]
19. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. Nielsen P; Günther U; Dürken M; Fischer R; Düllmann J J Lab Clin Med; 2000 May; 135(5):413-8. PubMed ID: 10811057 [TBL] [Abstract][Full Text] [Related]
20. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial. Depalma RG; Hayes VW; Chow BK; Shamayeva G; May PE; Zacharski LR J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]